Someone else can probably explain it better than me even
Someone else can probably explain it better than me even thought I currently hold both stocks right now. I haven’t held any stocks other than cydy in months.
We are waiting for some phase 3 data from NWBO and they presenting some information soon. Brain cancer is a huge market as well and personally I’ve always been interested in stocks that target it bc of few people I know who’ve had it. CNSP is another but I haven’t touched it in awhile. Too risky at this point.
Usually before data is released stocks run up. We should see a run up of the stock here as well leading up to the NASH results.
As far as price. CYDY is extremely undervalued but outside looking in a lot of investors imo have left due to uncertainty and a lot of failures. We’ve had a lot of negative things happen this past year. Some good but more bad imo. Out of all the bio stocks I still believe this to be #1 by far. The market isn’t always ahead of the game. I have buddy’s who never averaged down. Sorry but not sorry when this goes well past 5 dollars again. I’ll just say I told you so….
I don’t plan on holding NWBO more than a few days. Not saying it won’t run I just saw an easy 50 percent to be made since everyone has been waiting a long time for them to start making moves. Easy money imo. I might even sell tomorrow.
Like SNPX, once data is out if it’s good watch that sucker go to 5 - 190 like ANVS did. I made 5k buying a week before the data was out and letting it ride. Same with SLS ect.
I have about 100 stocks on my radar. I tend not to trade bc I don’t like being on my phone all the time checking the price while my kids jump on me. Seriously too stressful lol, so once in a blue moon I’ll jump on something like the ones I’ve named above. The extra money isn’t worth the headache so 99 percent of my money is here.
CYDY is a totally different animal imo. In a perfect world CYDY could be worth well over 500 per share in a few years and that wouldn’t surprise me at all where something like SNPX or NWBO won’t even come close to that.
Now would I be happy if we had a 30 dollar buyout right now. I mean I’d be a millionaire if that happens. Kinda hard to picture myself holding onto this stock past triple digits a few years from now.
Just wait we will have our turn again. This time I’ll sell at 10 just kidding probably not….
6
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Nervous Times for Semiconductor Stocks When the semiconductor sector started October like a high-speed train, I thought we might sail through this month without hitting turbulence. But then, in trotted some shaky AI revenue numbers, and bam, the whole sector took a hit off its October highs. The semiconductor stocks, led by giants like Taiwan Semiconductor Manufacturing...
Continue Reading
Now here's something that'll tickle your ophthalmologist's fancy—Haag-Streit USA has rolled out the Octopus 910, a slick piece of kit set to shake up visual field testing for glaucoma management. This time, they're getting in front of the competition, unveiling it at the Association for Research in Vision and Ophthalmology's 2026 shindig in New Orleans. With this new...
Continue Reading
The High-Stakes Race for Data Center Power These days, if you're not talking about data centers, you're probably a step behind the curve. AI's explosive growth is pushing data center developments across North America like never before. Larger campuses, hefty power densities—it's all happening at a pace that's got everyone scrambling. For folks like NOARK Electric, this...
Continue Reading
FDA Clearance: A Major Step for RingConn In a space where every tiny gadget-maker is desperately clawing for a regulatory nod, RingConn—a venture born from Shenzhen Ninenovo Technology Limited—has snagged an FDA 510(k) clearance (Clearance No. K260490) for their wearable Smart Ring that measures blood oxygen levels non-invasively. October 10, 2026, marked the day when...
Continue Reading
Breaking Down the AI Music Race In the wild world of music production, AI's making waves. Here's the thing though—it's all about how fast and how much it can churn out. Now, won't lie to you, that's impressive, but not the full picture. Pat Villaceran, the brain behind CITY JAM, is adamant that the real gold isn't just speed. It's the unique sound each artist brings to...
Continue Reading
Fresh from the Canary Islands' shores, STARMUS VIII has lifted the veil on two young powerhouses shaping tomorrow—Valeria Corrales and Aneeshwar Kunchala. These two have snagged coveted honors, crowning them as champions of their generation. Igniting Passion for Science and the Environment Valeria Corrales isn't just another face in the crowd; she’s the force behind a...
Continue Reading
A Boom in Self-Directed Investing Times are changing, folks. More people than ever are taking finance into their own hands, wielding smartphones like fiscal swords in the name of self-directed investment. No middlemen, no fancy office, just straight-up trading from wherever you might be perched. Four major platforms now boast over 41 million funded accounts combined, each...
Continue Reading
Defining Energy Horizons in Riyadh Mark those calendars, because as the global energy crowd descends on Riyadh from October 11 to 15, 2026, KAPSARC steps into the spotlight. As the National Partner at the 25th World Petroleum Congress (WPC), they're not just warming the bench—they're playing every position, shaking up the field of energy. Paving the Pathways with...
Continue Reading
A Thoughtful Look at Trust and Technology We're staring at an issue here that dives deep into the guts of how technology, AI in particular, is reshaping our professional landscape. The latest issue of the Phoenix Scholar, a publication from the University of Phoenix College of Doctoral Studies, is tackling big questions. It's that kind of brainy reading where you untangle...
Continue Reading
Embracing the Spirit of Climbing Connections Alright, so when's the last time you saw a brand digging into the human side of one rugged sport like climbing? That's where Kailas steps in, pulling us beyond gear talk into the trust and camaraderie that defines climbing. Their latest effort—dubbed “Stay Warm, Stay Together”—goes beyond mere technical prowess by...
Continue Reading
Top 5 Most Recently Viewed Articles
Making Mother's Day Special with Epson's EcoTank Printers Epson is paving the way for families to create memorable gifts this Mother's Day. With the EcoTank printers, crafting unique and heartfelt presents has never been easier. These printers offer a cartridge-free printing solution, allowing families to focus on their creative ideas without worrying about running out of...
Continue Reading
BioCity Biopharmaceutics Collaborates for Cancer Treatment BioCity Biopharmaceutics Co., Ltd., a forward-thinking biopharmaceutical company known for its innovative cancer treatment approaches, recently made a significant announcement regarding its clinical trial collaboration to explore the combination therapy of BC3195 and KEYTRUDA. This partnership aims to evaluate the...
Continue Reading
Exploring the Impacts of Early Retirement Contemplating the possibility of leaving the workforce can be a formidable thought for many individuals. The allure of retiring early often clashes with the realities of financial planning and ongoing expenses. A 45-year-old individual recently reflected on this dilemma, questioning whether it was feasible to semi-retire or pivot...
Continue Reading
Understanding the Growing Wildfire Threat In light of recent environmental changes, it has become clear that wildfires are escalating into a significant global threat. Willis, a WTW business, recognized this challenge and has partnered with the University of East Anglia (UEA) to enhance our understanding of wildfire risks. As these events increasingly rival losses caused...
Continue Reading
Current Investors Sentiment Towards AbbVie Investors with substantial capital are showing a positive outlook on AbbVie (NYSE: ABBV), and this shift is something important players in the market should notice. Recent observations have gathered data indicating a considerable rise in options trading for AbbVie, hinting that significant changes might soon unfold. Unusual...
Continue Reading